| mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.2 |
5e-05 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.19 |
5e-05 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
6e-05 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.17 |
7e-05 |
| mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0001 |
| mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |